Quantcast

Latest China Biologic Products Inc. Stories

2014-07-29 08:32:40

BEIJING, July 29, 2014 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release second quarter 2014 financial results on Tuesday, August 5, 2014 after the market closes. The Company's management will hold a conference call at 8:00 a.m. ET on Wednesday, August 6, 2014, which is 8:00 p.m., Beijing Time on August 6,...

2014-07-11 23:06:57

ChinaMarketResearchReports.com adds latest report on “China Blood Product Industry Report, 2014-2017” to its store. Inquire before buying this report at http://www.chinamarketresearchreports.com/contacts/inquire-before-buy.php?name=114862. Dallas, TX (PRWEB) July 11, 2014 Plasma resource reserves and control are crucial to the development of blood products industry. Although the closure of 16 plasma collection stations in Guizhou in 2011 didn’t cause major disruption to domestic...

2014-06-27 08:26:10

BEIJING, June 27, 2014 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced the pricing of a follow-on offering of 1,550,000 shares of common stock at a public offering price of $38.00 per share. The Company will be offering 800,000 shares and a selling stockholder will be offering 750,000 shares of common stock. In addition, the underwriters have a 30-day option to...

2014-06-23 08:27:48

BEIJING, June 23, 2014 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that on June 18, 2014, the Ministry of Finance of China and the State Administration of Taxation of China jointly published a notice to reduce and unify the value added tax ("VAT") rate on sales of a wide range of products in China, which will take effect on July 1, 2014. Pursuant to the...

2014-06-17 16:26:38

BEIJING, June 17, 2014 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that it filed a preliminary prospectus supplement in connection with the commencement of a public offering of shares of its common stock. The Company plans on selling 1,000,000 shares of common stock and certain selling stockholders plan on selling 2,212,500 shares of common stock in the...

2014-05-06 16:33:28

1Q14 Total Sales Increase 4.1% to $56.3Million BEIJING, May 6, 2014 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced its unaudited financial results for the first quarter of 2014. First Quarter 2014 Financial Highlights -- Total sales in the first quarter of 2014 increased by 4.1% to $56.3 million from $54.0 million in the same quarter of...

2014-04-29 08:36:38

BEIJING, April 29, 2014 /PRNewwire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release first quarter 2014 financial results on Tuesday, May 6, 2014 after the market closes. The Company's management will hold a conference call at 8:00 a.m. ET on Wednesday, May 7, 2014, which is 8:00 p.m., Beijing Time on May 7, 2014, to discuss...

2014-04-02 08:33:29

BEIJING, April 2, 2014 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company has learned that the pending claim in the High Court of Hong Kong (the "Court") against Ms. Siu Ling Chan ("Ms. Chan"), an individual shareholder of the Company, and her spouse, Mr. Tung Lam, had been withdrawn with Court approval. The claim was originally...

2014-03-19 08:29:30

BEIJING, March 19, 2014 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company has received the Good Manufacturing Practice ("GMP") certification from China Food and Drug Administration ("CFDA") in respect of its plasma production facility at its Guizhou subsidiary. Mr. David (Xiaoying) Gao, Chairman and Chief Executive Officer of...

2014-03-04 08:30:51

BEIJING, March 4, 2014 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release fourth quarter and fiscal year 2013 financial results on Wednesday, March 12, 2014 after the market closes. The Company's management will hold a conference call at 8:00 a.m. ET on Thursday, March 13, 2014, which is 8:00 p.m., Beijing Time on...


Word of the Day
toccata
  • In music, a work for a keyboard-instrument, like the pianoforte or organ, originally intended to utilize and display varieties of touch: but the term has been extended so as to include many irregular works, similar to the prelude, the fantasia, and the improvisation.
This word is Italian in origin, coming from the feminine past participle of 'toccare,' to touch.
Related